Utility of 18 F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease
Circulation: Cardiovascular Imaging · 2025
DOI: 10.1161/circimaging.125.018323 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Imaging, 2025. Verfasst von Diana M Lopez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Imaging Program, Departments of Medicine and Radiology (D.M.L., D.M.H., S. Divakaran, J.M.B., B.N.W., S. Dorbala, R.B., M.F.D.C.), Bri…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Fractional Flow Reserve, Myocardial, Coronary Artery Disease, Myocardial Perfusion Imaging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Absolute quantification of myocardial blood flow (MBF) on positron emission tomography perfusion imaging improves the identification of coronary artery disease (CAD). However, distinguishing MBF impairment due to obstructive CAD from nonobstructive CAD remains challenging. We aimed to evaluate the incremental diagnostic value of positron emission tomography derived relative flow reserve (RFR) in the diagnosis of obstructive CAD. METHODS: This is a post hoc analysis of the multicenter phase III trial of 18 F-flurpiridaz positron emission tomography. Patients with available MBF quantification were included. Reduced stress MBF (sMBF) was defined as sMBF below the median (2.2 mL/min per gram). Obstructive CAD on quantitative invasive coronary angiography was defined as ≥70% stenosis. RFR was calculated as a ratio of the minimal segment sMBF over the highest reference vascular territory sMBF. RFR performance for predicting obstructive CAD was evaluated through receiver operating characteristic analysis and the net reclassification index of multivariable regression models. RESULTS: The study included 231 patients (71% male; 56% with established CAD) drawn from the original cohort of 755 trial participants. No patients had 3-vessel CAD. In a per-vessel-based analysis, 82% of vessels with reduced sMBF had no obstructive CAD on invasive coronary angiography. RFR was significantly lower for vessels with obstructive CAD (0.55 versus 0.80; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Imaging Program, Departments of Medicine and Radiology (D.M.L., D.M.H., S. Divakaran, J.M.B., B.N.W., S. Dorbala, R.B., M.F.D.C.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (M.L., V.B., A.S., P.S.).
- Department of Radiology (Z.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Center for Clinical Investigation, Channing Division of Network Medicine (Z.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- GE Healthcare, Pharmaceutical Diagnostics, Buckinghamshire, United Kingdom (C.B.).
- Houston Methodist DeBakey Heart and Vascular Center, TX (M.H.A.-M.).
ORCID-Profile: Diana M Lopez, Daniel M Huck, Sanjay Divakaran, Jenifer M Brown, Brittany N Weber, Mark Lemley, Aakash Shanbhag, Mouaz H Al-Mallah, Sharmila Dorbala, Ron Blankstein, Piotr Slomka, Marcelo F Di Carli
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIBIB NIH HHS
- NCATS NIH HHS
Zitieren
APA
Lopez, D. M., Huck, D. M., Divakaran, S., Brown, J. M., Weber, B. N., Lemley, M., Builoff, V., Shanbhag, A., Lan, Z., Buckley, C., Al-Mallah, M. H., Dorbala, S., Blankstein, R., Slomka, P., & Di Carli, M. F. (2025). Utility of 18 F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.125.018323
Vancouver
Lopez DM, Huck DM, Divakaran S, Brown JM, Weber BN, Lemley M, et al. Utility of 18 F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease. Circulation: Cardiovascular Imaging. 2025. doi:10.1161/circimaging.125.018323
BibTeX
@article{Lopez2025,
author = {Lopez, Diana M and Huck, Daniel M and Divakaran, Sanjay and Brown, Jenifer M and Weber, Brittany N and Lemley, Mark and Builoff, Valerie and Shanbhag, Aakash and Lan, Zhou and Buckley, Christopher and Al-Mallah, Mouaz H and Dorbala, Sharmila and Blankstein, Ron and Slomka, Piotr and Di Carli, Marcelo F},
title = {Utility of 18 F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease},
journal = {Circulation: Cardiovascular Imaging},
year = {2025},
doi = {10.1161/circimaging.125.018323}
}
EUVIMED